Launched in March 2017, BigData@Heart is a five-year project of the Innovative Medicines Initiative (IMI), a public-private initiative between the European Union and the pharmaceutical industry association EFPIA.
BigData@Heart aims to develop a data-driven translational research platform towards improving patient outcomes and therefore reducing the societal burden of Atrial Fibrillation (AF), Acute Coronary Syndrome (ACS) and Heart Failure (HF) in Europe.